PFE vs RYN · P/E 20, rev $15.03B vs P/E 45, rev $484.5M
Pfizer Inc (PFE) versus Rayonier Inc (RYN) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Rayonier Inc (RYN) is a reit - specialty company listed on NYSE.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported RYN revenue for 2025-12-31 was $484.5M. Net income was $474.4M. Revenue was down 61.6% from 2024-12-31 to 2025-12-31. RYN currently screens at market cap $6.27B and trailing P/E 45.1.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. RYN currently screens at market cap $6.27B and trailing P/E 45.1.
Not investment advice. Open the PFE and RYN stock pages for the full models.
Not investment advice.